Yearly, when the Cupertino-based Apple goes to launch a brand new product, numerous sources create and launch renders of the upcoming gadgets. However a few of them are removed from having something in widespread with the truth and are made to drive visits to their web sites. On this regard, what a tipster John Prosser has been delivering in recent times might be referred to as almost-real renders’. Not too long ago, he has as soon as once more teamed up with idea artist Ian Zelbo to showcase the alleged design of the following technology of Apple Watch Sequence 7.
In truth, the Watch Sequence 7 must get a serious redesign. As a substitute of the curved edges, it would get flat edges. The brand new renders took this into consideration, and in addition, displayed different design parts. Furthermore, within the renders, we will see the Apple Watch with a mint inexperienced shade that matches the iPhone 12 and newest iPad Air.
As for the important thing options, the Apple Watch Sequence 7 ought to sport the identical 1.57-inch show on the smaller 40mm mannequin and a 1.78-inch display on the 44mm model. The show goes nonetheless to stay curvy like in previous years.
There isn’t a extra data regarding its {hardware}, however we’re additionally anticipating an up to date S7 chipset.
Blood Sugar Monitoring
Effectively, what we all know is that the Apple Watch Sequence 7 ought to assist blood sugar measurement. In truth, the data comes not from Apple however from Rockley Photonics, a UK-based firm. The latter has developed a expertise that makes use of infrared to watch human blood. This sensor can’t solely monitor coronary heart price, blood oxygen but in addition measure blood sugar and even alcohol ranges.
On this regard, Rockley Photonics CEO, Andrew Rickman, stated that their expertise can be utilized to shopper merchandise in 2022. When taking into consideration this assertion, the Apple Watch Sequence 7 might skip it. However the merchandise coming after that can use it.
As for the Apple half, it has a workforce of biomedical engineers and consultants which can be engaged on this expertise. Apple’s workforce focuses on non-implantable blood glucose monitoring sensors. In truth, the Cupertino firm is rumored to be testing this sensor at a medical web site within the San Francisco Bay Space.
